Discovery of a novel NUAK1 inhibitor against pancreatic cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Discovery of a novel NUAK1 inhibitor against pancreatic cancer

Published:2022-08 Issue: Volume:152 Page:113241
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Seo Myeong-Seong,Jung Kyung Hee,Kim Kewon,Lee Ji Eun,Han Beom Seok,Ko Soyeon,Kim Jae Ho,Hong Sungwoo,Lee So Ha,Hong Soon-Sun

Funder

Korea Institute of Science and Technology

National Research Foundation of Korea

Institute for Basic Science

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference46 articles.

1. Epidemiology of pancreatic cancer: global trends, etiology and risk factors;Prashanth;World J. Oncol.,2019

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018

3. Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma;Grossberg;CA. Cancer J. Clin.,2020

4. Immunotherapy for pancreatic cancer: a 2020 update;Schizas;Cancer Treat. Rev.,2020

5. Pancreatic cancer chemoresistance to gemcitabine;Amrutkar;Cancers,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chiroptical sensing for remote chiral amines via a C-H activation reaction;Chinese Chemical Letters;2024-08

2. Anti‐NSCLC role of SCN4B by negative regulation of the cGMP‐PKG pathway: Integrated utilization of bioinformatics analysis and in vitro assay validation;Drug Development Research;2024-04-28

3. NUAK1 coordinates growth factor-dependent activation of mTORC2 and Akt signaling;Cell & Bioscience;2023-12-22

4. NUAK1 governs centrosome replication in pancreatic cancer via MYPT1/PP1β and GSK3β‐dependent regulation of PLK4;Molecular Oncology;2023-04-03

5. DKK1 promotes NUAK1 transcriptional expression through the activation Akt in hepatocellular carcinoma;Cell Biology International;2022-12-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3